FDA Inspection 1272748 - 3D Imaging Drug Design and Development - June 13, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore 3D Imaging Drug Design and Development

Record Details

This FDA Inspection record concerns 3D Imaging Drug Design and Development, with an inspection on June 13, 2025, issued by the Dallas District Office, covering human drugs.

Company: 3D Imaging Drug Design and Development
Inspection Date: June 13, 2025
Product Type: Human Drugs
Office: Dallas District Office

Open in Dashboard

ID · 110c05b6-92ad-4ba6-a7b3-089d7293b2a5

Violation Codes6

21 CFR 212.20(e)21 CFR 212.30(b)21 CFR 212.40(b)21 CFR 212.5021 CFR 212.60(c)21 CFR 212.60(e)

Full citation text and observation details available on the Dashboard.